Cargando…

Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study

BACKGROUND: Phase 3 studies suggest that induction chemotherapy (ICT) of cisplatin and 5-fluorouracil plus docetaxel (TPF) is effective but toxic for patients with squamous-cell carcinoma of the head and neck (SCCHN). Dose-dense chemotherapy may yield favorable outcomes compared with standard-dose c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Ching-Yun, Lein, Ming-Yuh, Yang, Shih-Neng, Wang, Yao-Ching, Lin, Yin-Jun, Lin, Chen-Yuan, Hua, Chun-Hung, Tsai, Ming-Hsul, Lin, Ching-Chan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7465725/ https://www.ncbi.nlm.nih.gov/pubmed/32873270 http://dx.doi.org/10.1186/s12885-020-07347-6

Ejemplares similares

Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers
por: Bernadach, Maureen, et al.
Publicado: (2021)

TPF induction chemotherapy increases PD-L1 expression in tumour cells and immune cells in head and neck squamous cell carcinoma
por: Leduc, Charlotte, et al.
Publicado: (2018)

Chemotherapy dose per kilogram lean body mass increased dose-limiting toxicity event in male head and neck cancer with taxane and platinum-based induction therapy
por: Hung, Chuan-Jen, et al.
Publicado: (2022)

Low p16 Cytoplasmic Staining Predicts Poor Treatment Outcome in Patients with p16-Negative Locally Advanced Head and Neck Squamous Cell Carcinoma Receiving TPF Induction Chemotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2023)

Serum Levels of Stromal Cell-Derived Factor-1α and Vascular Endothelial Growth Factor Predict Clinical Outcomes in Head and Neck Squamous Cell Carcinoma Patients Receiving TPF Induction Chemotherapy
por: Chen, Yen-Hao, et al.
Publicado: (2022)

Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients
por: Fayette, Jérôme, et al.
Publicado: (2016)

In search for optimal induction chemotherapy for advanced nasopharyngeal cancer: Standard dosing of Docetaxel, Platinum, and 5-Fluorouracil (TPF) followed by chemoradiation
por: Jun, Michelle, et al.
Publicado: (2023)

Taxanes in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Hsieh, Ching-Yun, et al.
Publicado: (2023)

Effect of Exercise Training on Exercise Tolerance and Level of Oxidative Stress for Head and Neck Cancer Patients Following Chemotherapy
por: Yen, Chia-Jui, et al.
Publicado: (2020)

Neoadjuvant chemotherapy with different dose regimens of docetaxel, cisplatin and fluorouracil (TPF) for locoregionally advanced nasopharyngeal carcinoma: a retrospective study
por: Jin, Ting, et al.
Publicado: (2017)

Pretreatment monocyte counts and neutrophil counts predict the risk for febrile neutropenia in patients undergoing TPF chemotherapy for head and neck squamous cell carcinoma
por: Shimanuki, Marie, et al.
Publicado: (2018)

Effects of Exercise in Patients Undergoing Chemotherapy for Head and Neck Cancer: A Pilot Randomized Controlled Trial
por: Lin, Kuan-Yin, et al.
Publicado: (2021)

Addition of Nimotuzumab to Standard TPF Regimen in Locally Advanced Head and Neck Cancer: A Single Institutional Study
por: Koramati, Samuel Luke, et al.
Publicado: (2021)

Two postoperative chemotherapies for gastric cancer: FOLFOX4 vs. TPF
por: Xie, Honghu, et al.
Publicado: (2019)

Feasibility of Induction Docetaxel, Cisplatin, 5-Fluorouracil, Cetuximab (TPF-C) Followed by Concurrent Cetuximab Radiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma
por: Charalambakis, Nikolaos, et al.
Publicado: (2013)

A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas
por: Ansari, M, et al.
Publicado: (2011)

Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx - TPF-C-HIT
por: Jensen, Alexandra D, et al.
Publicado: (2011)

Rituximab in combination with gemcitabine plus cisplatin in patients with recurrent and metastatic head and neck squamous cell carcinoma: a phase I trial
por: Hsieh, Ching-Yun, et al.
Publicado: (2022)

Effect of CADM1 on TPF-induced chemotherapy in laryngeal squamous cell carcinoma
por: Nie, Jiani, et al.
Publicado: (2023)

Statin and the Risk of Ischemic Stroke or Transient Ischemic Attack in Head and Neck Cancer Patients with Radiotherapy
por: Lee, Bo-Ching, et al.
Publicado: (2018)

Increased response to TPF chemotherapy promotes immune escape in hypopharyngeal squamous cell carcinoma
por: Li, Ruichen, et al.
Publicado: (2023)

Comparison of TPF and TP Induction Chemotherapy for Locally Advanced Nasopharyngeal Carcinoma Based on TNM Stage and Pretreatment Systemic Immune-Inflammation Index
por: Xiong, Ying, et al.
Publicado: (2021)

Deciphering the Functions of Telomerase Reverse Transcriptase in Head and Neck Cancer
por: Yeh, Tsung-Jang, et al.
Publicado: (2023)

Outcomes of Induction Chemotherapy for Head and Neck Cancer Patients: A Combined Study of Two National Cohorts in Taiwan
por: Chen, Jin-Hua, et al.
Publicado: (2016)

Associations of Head and Neck Cancer with Hepatitis B Virus and Hepatitis C Virus Infection
por: Hung, Shih-Han, et al.
Publicado: (2023)

Long-term results of a randomized phase III trial of TPF induction chemotherapy followed by surgery and radiation in locally advanced oral squamous cell carcinoma
por: Zhong, Lai-ping, et al.
Publicado: (2015)

Targeting mTOR-CCL20 Signaling May Improve Response to Docetaxel in Head and Neck Squamous Cell Carcinoma
por: Chou, Ming-Huei, et al.
Publicado: (2021)

Long-Term Survival and Prognostic Factors in Locoregionally Advanced Nasopharyngeal Carcinoma Patients Treated with TPF Induction Chemotherapy followed by Cisplatin-Combined Concurrent Chemoradiotherapy
por: Zhang, Qun, et al.
Publicado: (2019)

Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF) in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN)
por: Katori, H, et al.
Publicado: (2004)

Clinical impact of albumin in advanced head and neck cancer patients with free flap reconstruction—a retrospective study
por: Tsai, Ming-Hsien, et al.
Publicado: (2018)

7-Epitaxol Induces Apoptosis and Autophagy in Head and Neck Squamous Cell Carcinoma through Inhibition of the ERK Pathway
por: Kumar, V. Bharath, et al.
Publicado: (2021)

Impact of body-mass factors on setup displacement in patients with head and neck cancer treated with radiotherapy using daily on-line image guidance
por: Lai, Yo-Liang, et al.
Publicado: (2014)

Effect of Induction Chemotherapy on Swallowing in Head and Neck Cancer Patients
por: Portas, Juliana, et al.
Publicado: (2019)

Comparison of therapeutic efficacy and toxicity of docetaxel, cisplatin, and fluorouracil (TPF)-based induction chemotherapy plus concurrent chemoradiotherapy and chemoradiotherapy alone in locally advanced nasopharyngeal carcinoma
por: Chen, Ruijuan, et al.
Publicado: (2021)

Dihydroisotanshinone I as a Treatment Option for Head and Neck Squamous Cell Carcinomas
por: Hsu, Cheng-Ming, et al.
Publicado: (2021)

6-shogaol is a potential treatment for Head and Neck Squamous Cell Carcinoma
por: Hsu, Cheng-Ming, et al.
Publicado: (2023)

The application of ultrasound in detecting lymph nodal recurrence in the treated neck of head and neck cancer patients
por: Lin, Chi-Maw, et al.
Publicado: (2017)

Routine Endoscopy for Esophageal Cancer Is Suggestive for Patients with Oral, Oropharyngeal and Hypopharyngeal Cancer
por: Hung, Shih-Han, et al.
Publicado: (2013)

Correction: Routine Endoscopy for Esophageal Cancer Is Suggestive for Patients with Oral, Oropharyngeal and Hypopharyngeal Cancer
por: Hung, Shih-Han, et al.
Publicado: (2017)

Tumor Volume Reduction Rate to Induction Chemotherapy is a Prognostic Factor for Locally Advanced Head and Neck Squamous Cell Carcinoma: A Retrospective Cohort Study
por: Lin, Ting-Chun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_r3ce5tjf89atvh2scdb7ieodu4